Page last updated: 2024-11-12

xestoaminol c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

xestoaminol C: a metabolite of Fiji sponge, Xestospongia sp.; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-deoxytetradecasphinganine : A sphingoid that is tetradecasphinganine in which the terminal hydroxy group has been replaced by a hydrogen. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID14756407
CHEMBL ID448146
CHEBI ID73882
SCHEMBL ID5271731
MeSH IDM0452775

Synonyms (13)

Synonym
LMSP01080033
xestoaminol c
1-deoxy-tetradecasphinganine
CHEMBL448146
(2s,3r)-xestoaminol c
chebi:73882 ,
(2s,3r)-2-aminotetradecan-3-ol
1-deoxytetradecasphinganine
WMUMHAZHWIUBPN-UONOGXRCSA-N
(2s,3r)-2-amino-3-tetradecanol
SCHEMBL5271731
Q27144207
DTXSID001025435
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
sphingoidSphinganine, its homologs and stereoisomers, and the hydroxy and unsaturated derivatives of these compounds.
amino alcoholAn alcohol containing an amino functional group in addition to the alcohol-defining hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID623346Cytotoxicity against human SHG44 at 50 uM after 24 hrs by cell counting kit-8 assay2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Diastereoselective synthesis and bioactivity of long-chain anti-2-amino-3-alkanols.
AID623348Antiproliferative activity against human SHG44 cells after 24 hrs by cell counting kit-8 assay2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Diastereoselective synthesis and bioactivity of long-chain anti-2-amino-3-alkanols.
AID336239Inhibition of reverse transcriptase at 1 mg/ml
AID623347Growth inhibition of human SHG44 at 10 uM after 24 hrs by cell counting kit-8 assay2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Diastereoselective synthesis and bioactivity of long-chain anti-2-amino-3-alkanols.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.92 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]